Multiple Myeloma news from FierceHealthcare
NewsOur drug approval system is broken
Repeat after me: our drug approval system is broken. Or, if it's working right, then I don't want to see it when it really is broken. A recent example of this malfunction, which appears in Read more...
| Press ReleasesMayo Clinic Study May Help Physicians Determine How Patients Will Respond to Multiple Myeloma TherapySCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Research on the same protein that was a primary mediator of the birth defects caused by thalidomide now holds hope in the battle against multiple myeloma, say Read more >> Acetylon Pharmaceuticals Announces Completion of $27 Million Series B Round of Private Investor Financing- Funds Will Support Phase I/II Study of ACY-1215, the First Clinical Trial of a Class II-Selective Next Generation HDAC Inhibitor - - Acetylon CEO Walter Ogier to Participate on a Start-up Finance Read more >> The International Myeloma Foundation Says Major Medical Meeting in Paris Will Support New Treatment Options for Patients--Anticipate Survival Advantage with Long-Term Continuous Treatment-- --More Evidence Supporting Next-Generation Pipeline Drugs-- --Journalist Workshop to be Webcast May 5-- --Patient and Family Read more >> New Multiple Myeloma Treatment Guidelines for Patients Available from NCCNThe National Comprehensive Cancer Network® (NCCN®) has released the NCCN Guidelines for Patients™: Multiple Myeloma, available free of charge on NCCN.com. NCCN Guidelines for Patients™ are a new tool Read more >> |
